Interdisciplinary Unit for the treatment of hepatocellular carcinoma

Hepatic carcinoma is one of the major health problems in both Western countries and developing regions of the world, and its presence is expected to increase even further in the coming years. Treatment depends on the extent of the disease and the degree of liver dysfunction, since about 90% of cancers occur in an already cirrhotic liver. The choice of the best treatment is linked to the high specialisation of our professional as well as to a multidisciplinary discussion.

Treatments available at the University Campus Bio-Medico Hospital are the following:

  • potentially radical treatments, such as liver resection or hyperthermia through percutaneous thermal ablation (radiofrequency ablation RFA, or microwave ablation, MWA)
  • treatments that consist in the selective endovascular injection of microspheres loaded with a chemotherapy agent, targeting vessels that feed the tumour (also called chemoembolisation)
  • systemic chemotherapy with Sorafenib or Regorafenib

If the case examined is sensitive to liver transplantation or radio-embolic treatment, the patient is then presented to the reference centres for the disease.

The Interdisciplinary Unit for the treatment of hepatocellular carcinoma was founded in 2009 with the aim of promoting an interdisciplinary approach. It is responsible for the assessment and treatment of patients with primary liver cancer (hepatocellular carcinoma and cholangiocarcinoma), with support from the Clinical Medicine and Hepatology Unit and in collaboration with the Units of Medical OncologyDiagnostic Imaging and General Surgery.